AVIR · Atea Pharmaceuticals, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-18 | Lucidi Bruno |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2026. |
Restricted Stock Units
|
29,600 |
| 2026-06-18 | Murphy Polly A. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
Common Stock
|
29,600 |
| 2026-06-18 | Polsky Bruce |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date. |
Stock Option (Right to Buy)
|
37,700 |
| 2026-06-18 | Polsky Bruce |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date. |
Restricted Stock Units
|
26,700 |
| 2026-06-18 | Berman Howard |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date. |
Restricted Stock Units
|
26,700 |
| 2026-06-18 | Adams Jerome M. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
Common Stock
|
29,600 |
| 2026-06-18 | BERGER FRANKLIN M |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
Common Stock
|
29,600 |
| 2026-06-18 | Adams Jerome M. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date. |
Stock Option (Right to Buy)
|
37,700 |
| 2026-06-18 | Duncan Barbara Gayle |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date. |
Stock Option (Right to Buy)
|
37,700 |
| 2026-06-18 | BERGER FRANKLIN M |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2026. |
Restricted Stock Units
|
29,600 |
| 2026-06-18 | Kirsch Arthur S |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date. |
Stock Option (Right to Buy)
|
37,700 |
| 2026-06-18 | Kirsch Arthur S |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date. |
Restricted Stock Units
|
26,700 |
| 2026-06-18 | Duncan Barbara Gayle |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
Common Stock
|
29,600 |
| 2026-06-18 | Murphy Polly A. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2026. |
Restricted Stock Units
|
29,600 |
| 2026-06-18 | Lucidi Bruno |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date. |
Stock Option (Right to Buy)
|
37,700 |
| 2026-06-18 | BERGER FRANKLIN M |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date. |
Stock Option (Right to Buy)
|
37,700 |
| 2026-06-18 | Lucidi Bruno |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date. |
Restricted Stock Units
|
26,700 |
| 2026-06-18 | Duncan Barbara Gayle |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2026. |
Restricted Stock Units
|
29,600 |
| 2026-06-18 | BERGER FRANKLIN M |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date. |
Restricted Stock Units
|
26,700 |
| 2026-06-18 | Murphy Polly A. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date. |
Stock Option (Right to Buy)
|
37,700 |
| 2026-06-18 | Polsky Bruce |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2026. |
Restricted Stock Units
|
29,600 |
| 2026-06-18 | Adams Jerome M. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2026. |
Restricted Stock Units
|
29,600 |
| 2026-06-18 | Lucidi Bruno |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
Common Stock
|
29,600 |
| 2026-06-18 | Adams Jerome M. |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date. |
Restricted Stock Units
|
26,700 |
| 2026-06-18 | Berman Howard |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date. |
Stock Option (Right to Buy)
|
37,700 |
| 2026-06-18 | Murphy Polly A. |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date. |
Restricted Stock Units
|
26,700 |
| 2026-06-18 | Polsky Bruce |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
Common Stock
|
29,600 |
| 2026-06-18 | Duncan Barbara Gayle |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date. |
Restricted Stock Units
|
26,700 |
| 2026-05-18 | Murphy Polly A. |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
This Form 4/A has been filed solely to correct the date of the transaction reported in Column 2 of Table I of the Reporting Person's Form 4 filed on May 20, 2026, which was inadvertently noted as "May 18, 2025" instead of "May 18, 2026." The price reported in Column 4 is a weighted average price. The securities were purchased in multiple transactions at prices ranging from $4.14 to $4.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
Common Stock
|
6,100 |
| 2026-03-11 | Corcoran Andrea |
See Remarks |
Convert↑
|
Common Stock
|
60,000 |
| 2026-03-11 | Corcoran Andrea |
See Remarks |
Convert↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option is fully vested and exercisable. |
Stock Option (Right to Buy)
|
60,000 |
| 2026-02-03 | Sommadossi Jean-Pierre |
Director, President, CEO, and Chairman |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option is fully vested and exercisable. |
Stock Option (Right to Buy)
|
300,000 |
| 2026-02-03 | Sommadossi Jean-Pierre |
Director, President, CEO, and Chairman |
Convert↑
|
Common Stock
|
300,000 |
| 2026-01-31 | Foster Wayne |
EVP, Chief Accounting Officer |
Tax↓
|
Common Stock
|
12,132 |
| 2026-01-31 | Vavricka John |
Chief Commercial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
Common Stock
|
42,083 |
| 2026-01-31 | Horga Maria Arantxa |
Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The original grant of 124,600 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026. |
Restricted Stock Units
|
41,533 |
| 2026-01-31 | Vavricka John |
Chief Commercial Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030. |
Stock Option (Right to Buy)
|
119,520 |
| 2026-01-31 | Sommadossi Jean-Pierre |
Director, President, CEO, and Chairman |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Reflected one (1) share correction due to prior administrative rounding error with respect to RSU vesting in 2026. Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026. |
Restricted Stock Units
|
99,517 |
| 2026-01-31 | Vavricka John |
Chief Commercial Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026. |
Restricted Stock Units
|
8,750 |
| 2026-01-31 | Sommadossi Jean-Pierre |
Director, President, CEO, and Chairman |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The original grant of 520,400 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026. |
Restricted Stock Units
|
173,466 |
| 2026-01-31 | Foster Wayne |
EVP, Chief Accounting Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030. |
Stock Option (Right to Buy)
|
108,000 |
| 2026-01-31 | Corcoran Andrea |
See Remarks |
Tax↓
|
Common Stock
|
16,104 |
| 2026-01-31 | Hammond Janet MJ |
Chief Development Officer |
Tax↓
|
Common Stock
|
14,136 |
| 2026-01-31 | Corcoran Andrea |
See Remarks |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Includes 7,507 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan. |
Common Stock
|
54,866 |
| 2026-01-31 | Foster Wayne |
EVP, Chief Accounting Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The original grant of 100,000 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026. |
Restricted Stock Units
|
33,333 |
| 2026-01-31 | Vavricka John |
Chief Commercial Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The original grant of 100,000 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026. |
Restricted Stock Units
|
33,333 |
| 2026-01-31 | Sommadossi Jean-Pierre |
Director, President, CEO, and Chairman |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
Common Stock
|
272,983 |
| 2026-01-31 | Horga Maria Arantxa |
Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026. |
Restricted Stock Units
|
9,750 |
| 2026-01-31 | Foster Wayne |
EVP, Chief Accounting Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026. |
Restricted Stock Units
|
8,000 |
| 2026-01-31 | Hammond Janet MJ |
Chief Development Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026. |
Restricted Stock Units
|
11,250 |